PridCor Therapeutics Advances SHIELD Study Through Dual Regulatory and Scientific Milestones With Peer-Reviewed Publication and FDA IND Exemption for Long COVI…

PridCor Therapeutics, a clinical-stage biopharmaceutical company developing antiviral therapies for infection-associated ...
eLife

Decoding the biogenesis of HIV-induced CPSF6 puncta and their fusion with nuclear speckles

HIV hijacks SRRM2 to enlarge nuclear speckles, stabilizing CPSF6 puncta and promoting efficient viral replication.

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

The Burn Pit Initiative is expected to serve as a foundational program within a broader biodefense framework that may be extended to additional exposure-related and environmental health threats.

Milestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption in Dentistry

Pilot launched with six registered dental professionals; program expected to scale to 250 ambassadors over 12 monthsROSELAND, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: ...